ArticleScientific reports2025
Unraveling molecular mechanisms of cigarette smoke bitterness via chemical profiling and bitter taste receptor activation analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Tobacco metabolites play a crucial role in shaping the sensory experience of tobacco products, such as cigarettes. Bitter metabolites in tobacco not only serve as protective agents in plants, but also significantly influence the overall flavor profile of cigarettes. In this study, we employed an integrated approach combining chemical profiling, cell-based calcium imaging assays, and molecular docking studies to identify key bitter compounds in cigarette smoke and explore the molecular mechanisms underlying their bitterness. We analyzed 22 commercial cigarette brands, revealing notable variability in bitterness perception. GC-MS analysis identified 88 compounds in mainstream cigarette smoke (MCS), with pyridines, esters, and phenols being the most prevalent. Using a TAS2R14-Gα16gust44-HEK293T cell-based assay, we objectively measured bitterness and identified nicotine, succinimide, and scopoletin as key bitter compounds through correlation analysis. Molecular docking studies provided detailed insights into the interactions of these compounds with the TAS2R14 receptor, highlighting significant hydrogen bonding and hydrophobic interactions. This integrated methodology not only identifies key contributors to cigarette bitterness but also enhances our understanding of the molecular basis of bitterness perception in tobacco. These findings pave the way for future studies to further elucidate the complex interactions of bitter compounds. This understanding of the links between tobacco bitterness and consumption holds significant implications for public health and tobacco control initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.